ArticleFrontiers in pharmacology2022

Ponatinib modulates the metabolic profile of obese mice by inhibiting adipose tissue macrophage inflammation.

Zhuomiao Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.